News and Trends 15 Dec 2022
EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation
…candidate for the treatment of Canavan disease (CD). EMA OD designation’s aim is to encourage the development of treatments for life-threatening rare conditions by providing incentives such as protocol assistance,…
